1. Pharma Companies in Gujarat

When it comes to pharmaceutical manufacturing in India, one state stands clearly ahead of the curve—Gujarat. With a legacy of industrial excellence, regulatory compliance, and global export strength, Gujarat has established itself as India’s pharmaceutical powerhouse. Whether it’s bulk drugs (APIs), complex formulations, or biologics, the state consistently leads in both volume and value.

Today, nearly 30% of India’s total pharmaceutical production originates in Gujarat. The state is home to more than 5,000 licensed drug manufacturing units, ranging from Fortune 500-listed pharmaceutical giants to high-growth MSMEs. From Ahmedabad and Vadodara to Ankleshwar and Vapi, pharma companies in Gujarat serve not just Indian demand—but also supply medicines to over 200 countries worldwide.

This guide provides a comprehensive view into Gujarat’s pharma landscape: the top companies, key manufacturing hubs, policy support, global exports, and what lies ahead in this rapidly evolving sector. Whether you’re a pharmaceutical buyer, business owner, investor, regulatory expert, or job seeker—this article will help you navigate everything you need to know about pharma companies in Gujarat in 2025 and beyond.

2. Why Gujarat Leads India’s Pharma Manufacturing

Gujarat’s dominance in the pharmaceutical sector isn’t incidental—it’s the result of decades of industrial development, business-friendly policies, and an unmatched ecosystem for production and export. Several factors have propelled the state to the forefront of the pharma value chain, making it a global player in the life sciences industry.

1. Legacy of Industrial and Pharmaceutical Excellence

• Gujarat has been a manufacturing-oriented state since the 1960s, and pharmaceuticals became a priority industry by the 1980s.
   
• Cities like Ahmedabad and Vadodara were among the first in India to establish large-scale formulation plants and chemical research labs.
   
• The presence of legacy companies like Alembic, Zydus, Cadila Pharmaceuticals, and Torrent has laid the groundwork for a robust ecosystem.
   

2. Strong Support from State Government

• The Gujarat Industrial Policy 2020 offers capital subsidies, interest assistance, and stamp duty exemptions for pharma companies.
   
• The government has developed dedicated pharma zones with pre-approved infrastructure and fast-track approvals through the Gujarat Industrial Development Corporation (GIDC).
   
• Gujarat is one of the few states with pharma-specific plug-and-play parks in Sanand, Dahej, and Vadodara.
   

3. World-Class Infrastructure and Port Connectivity

• Gujarat has a robust transport and logistics infrastructure, including:
   
  • Two major seaports (Mundra and Kandla)
     
  • 11 inland container depots (ICDs)
     
  • Dedicated freight corridors connecting to Delhi, Mumbai, and northern India
     
• These facilities give pharma companies in Gujarat a global reach for bulk drug and formulation exports.
   

4. Regulatory and Quality Excellence

• Gujarat hosts over 130 USFDA-approved manufacturing plants—the highest among all Indian states.
   
• It also leads in WHO-GMP, MHRA (UK), and EU-GMP certified facilities, proving its dominance in regulatory-compliant manufacturing.
   
• Ahmedabad serves as a central hub for regulatory consulting, pharmacovigilance, and dossier filing services.
   

5. Skilled Workforce and Pharma Education

• The state is home to institutes like:
   
  • National Institute of Pharmaceutical Education and Research (NIPER-Gandhinagar)
     
  • LM College of Pharmacy (Ahmedabad)
     
  • MS University of Baroda
     
• These institutions feed Gujarat’s pharma industry with highly skilled talent in formulation science, process engineering, clinical trials, and quality control.
   

Together, these factors make pharma companies in Gujarat not just efficient producers—but also globally trusted partners for compliant, high-quality, and scalable drug manufacturing.

3. Classification of Pharma Companies in Gujarat

The pharmaceutical ecosystem in Gujarat is vast and varied. From multinational corporations to contract research organizations and herbal medicine producers, the state supports all types of pharma enterprises. For a better understanding of Gujarat’s strengths and opportunities, here’s how we can classify pharma companies in Gujarat based on their business models, specialization, and scale.

A. By Product Focus

1. API Manufacturers (Bulk Drugs)

• Gujarat leads the country in Active Pharmaceutical Ingredient (API) production.
   
• Key API zones include Ankleshwar, Dahej, and Panoli.
   
• Companies specialize in penicillin derivatives, anti-diabetics, NSAIDs, and oncology APIs.
   

2. Formulation Companies

• These companies manufacture finished dosage forms: tablets, capsules, injectables, ointments, and syrups.
   
• Ahmedabad and Vadodara are leading formulation hubs with facilities approved by USFDA, TGA, and WHO-GMP.
   

3. Biopharmaceutical and Biosimilar Companies

• Vadodara and Ahmedabad are also emerging as centers for biotech-driven drug development.
   
• Firms here develop biosimilars, monoclonal antibodies, vaccines, and gene-based therapeutics.
   

4. Veterinary Pharma and Animal Healthcare

• Gujarat houses a growing number of animal drug manufacturers, producing feed additives, injectables, and veterinary antibiotics.
   

5. Herbal, Ayurvedic, and Nutraceutical Units

• Backed by rich natural resources and traditional medicine expertise, several Gujarat-based firms manufacture:
   
  • Herbal syrups and tablets
     
  • Ayurvedic skin and digestion products
     
  • FSSAI-certified nutraceuticals
     

B. By Business Model

1. R&D-Focused Innovators

• Companies with in-house research centers developing novel molecules, complex generics, or drug delivery systems.
   

2. CRAMS Providers (Contract Research and Manufacturing Services)

• Gujarat is a leader in CRAMS, offering end-to-end support to global pharmaceutical brands—from pre-clinical trials to large-scale manufacturing.
   

3. Export-Oriented Enterprises

• Firms that focus entirely on regulated market exports to the US, EU, Canada, and Japan.
   
• These companies hold DMFs, ANDAs, and EU CEPs for their products.
   

4. PCD and Franchise-Based Companies

• Gujarat also has thousands of marketing-based pharmaceutical companies that operate under PCD/franchise models.
   

C. By Scale

1. Large Enterprises / Multinational Corporations

• Includes Zydus Lifesciences, Torrent Pharma, Sun Pharma (facilities), Alembic Pharma, and Intas.
   
• These firms invest in global markets, clinical research, and product innovation.
   

2. Mid-Sized Manufacturers

• These firms manufacture generics and branded generics and often act as third-party partners for Indian and global companies.
   

3. MSMEs and Startups

• Operating from industrial estates in Ankleshwar, Vapi, and Nandesari, these smaller units serve the domestic and semi-regulated markets.
   

This classification shows how pharma companies in Gujarat cover the full pharmaceutical spectrum—from raw material suppliers to branded export leaders.

4. Top 15 Pharma Companies in Gujarat (2025 List)

Gujarat is home to some of the most reputable and globally recognized pharmaceutical companies in India. These firms contribute significantly to exports, R&D, and healthcare access both in India and across the world.

Here’s a list of the top 15 pharma companies in Gujarat based on regulatory approvals, product diversity, export reach, and innovation strength:

Company Name	Headquarters	Core Specialization	Certifications
Zydus Lifesciences	Ahmedabad	Biosimilars, vaccines, oncology, generics	USFDA, EU-GMP, WHO-GMP
Torrent Pharma	Ahmedabad	Cardiovascular, CNS, diabetology	USFDA, MHRA, TGA
Sun Pharma (Units)	Halol, Vadodara	Oncology, dermatology, generics	USFDA, EU-GMP, TGA
Intas Pharmaceuticals	Ahmedabad	Biologics, neuropsychiatry, oncology	USFDA, EMA, PMDA (Japan)
Alembic Pharmaceuticals	Vadodara	Anti-infectives, anti-diabetics, APIs	USFDA, WHO-GMP
Cadila Pharmaceuticals	Dholka	Critical care, herbal products, APIs	WHO-GMP, ISO Certified
Dishman Carbogen Amcis	Ahmedabad	CRAMS, oncology APIs	USFDA, Swissmedic
Amneal Pharma (India)	Ahmedabad	Complex generics, ophthalmology	USFDA, TGA, Health Canada
Lincoln Pharmaceuticals	Ahmedabad	Formulations (300+ products)	WHO-GMP, ISO 9001
Aculife Healthcare	Ahmedabad	Large-volume injectables, hospital supplies	WHO-GMP, ISO 13485
Eris Lifesciences	Ahmedabad	Lifestyle diseases (cardiac, diabetes)	NABL, ISO 9001
Claris Lifesciences	Ahmedabad	Sterile injectables, critical care	USFDA (sold to Baxter)
Troikaa Pharma	Ahmedabad	Pain management, injectables	WHO-GMP, ISO 9001
Vasu Healthcare	Vadodara	Ayurvedic and herbal products	AYUSH, FSSAI, ISO Certified
Centurion Remedies	Vadodara	Export-focused branded generics	WHO-GMP, Semi-regulated Markets

 

Note: Several of these companies have R&D centers and multiple manufacturing plants across GIDC zones in Gujarat, reflecting the state’s industrial depth.

This list highlights the diversity and global relevance of pharma companies in Gujarat, many of which are helping position India as a leader in affordable, high-quality healthcare worldwide.

5. Major Pharma Industrial Zones in Gujarat

One of the greatest advantages for pharma companies in Gujarat is access to well-planned, government-supported industrial infrastructure. The state has built a network of pharma-specific GIDC estates, SEZs, and industrial parks that provide plug-and-play facilities, regulatory support, and cost-effective utilities for manufacturers of all sizes.

Below are the most important pharmaceutical industrial clusters in Gujarat:

A. Ahmedabad – R&D, HQs, and Formulation Facilities

• Ahmedabad is the administrative and R&D headquarters of Gujarat’s pharmaceutical ecosystem.
   
• Hosts major brands like Zydus Lifesciences, Intas, Cadila, Torrent, Amneal, and Lincoln.
   
• Known for:
   
  • World-class R&D centers
     
  • Global regulatory compliance offices
     
  • Marketing and export coordination hubs
     
  • Formulation plants for tablets, capsules, and injectables
     

B. Vadodara – Specialty APIs and Export Manufacturing

• A prominent cluster for:
   
  • API production
     
  • Sterile injectables
     
  • Oncology formulations
     
• Home to Alembic, Troikaa, Vasu Healthcare, and Dishman.
   
• The presence of large chemical parks has enabled vertical integration for many companies.
   

C. Ankleshwar – India’s Largest Bulk Drug Zone

• Considered India’s bulk drug capital, with over 250 pharma and chemical manufacturing units.
   
• Specializes in:
   
  • APIs and intermediates
     
  • Solvent recovery
     
  • High-volume chemical synthesis
     
• Supported by:
   
  • CETP (Common Effluent Treatment Plant)
     
  • Cluster-based pollution control
     
  • GIDC’s pharma-focused development policy
     

D. Vapi – Formulations and Intermediate Chemicals

• Vapi GIDC is known for:
   
  • Contract manufacturing of general formulations
     
  • Production of drug intermediates and excipients
     
  • Strong presence of MSMEs exporting to Africa, Asia, and Latin America
     

E. Dahej SEZ – Large-Scale, Export-Oriented API Units

• Houses large, export-focused manufacturing units due to its:
   
  • Strategic location near the coast
     
  • Access to Mundra and Kandla ports
     
  • Availability of bulk land for API and fine chemical industries
     

F. Sanand – New-Gen Pharma & Biotech Park

• Planned as Gujarat’s future-facing pharma biotech innovation cluster.
   
• Hosts startups and mid-sized companies in:
   
  • Biologics
     
  • Green chemistry
     
  • High-value injectables
     
• Benefits from proximity to Ahmedabad’s talent and infrastructure.
   

These zones ensure that pharma companies in Gujarat are supported by the right environment for every stage—whether R&D, formulation, API production, or international distribution.

6. Gujarat’s Global Export Strength

One of the defining characteristics of pharma companies in Gujarat is their massive contribution to India’s pharmaceutical exports. Gujarat alone accounts for 30–40% of India’s total pharma exports, making it not just a national leader—but a critical link in the global healthcare supply chain.

Here’s how Gujarat leads the way in global pharma exports:

1. Contribution to India’s Export Economy

• Gujarat exports pharmaceuticals to over 200 countries, including:
   
  • United States
     
  • United Kingdom
     
  • Germany
     
  • South Africa
     
  • Brazil
     
  • Vietnam
     
• Key export products include:
   
  • APIs
     
  • Finished formulations
     
  • Biologics
     
  • Veterinary drugs
     
  • Herbal and nutraceutical products
     

2. Global Certifications & Compliance

• Gujarat is home to over 130 USFDA-approved plants, the highest in India.
   
• Companies hold:
   
  • DMFs (Drug Master Files)
     
  • CEP (Certificate of Suitability by EU)
     
  • TGA and Health Canada approvals
     
  • MOH certifications for semi-regulated markets
     

This enables pharma companies in Gujarat to serve both regulated markets like the US/EU and high-growth semi-regulated regions in Africa, Asia, and Latin America.

3. Logistics and Port Connectivity

• Gujarat’s edge in exports is also powered by unmatched connectivity:
   
  • Mundra Port (India’s largest private port)
     
  • Kandla Port (for containerized pharma shipping)
     
  • Ahmedabad ICD (Inland Container Depot) for temperature-sensitive exports
     
• Dedicated cold chain logistics and air freight options via Ahmedabad and Vadodara make it easy to move high-value pharma products globally.
   

4. Export-Driven Manufacturing Strategies

• Many Gujarat-based pharma firms have adopted:
   
  • Dedicated export units with separate regulatory lines
     
  • Co-marketing partnerships with MNCs
     
  • Custom manufacturing for foreign generic brands
     

This has positioned Gujarat as India’s most export-ready state when it comes to pharmaceuticals—both in volume and compliance standards.

7. Government Support and Policies

One of the primary reasons pharma companies in Gujarat have flourished is the state’s proactive and business-friendly policy environment. Gujarat has consistently aligned its industrial growth plans with the needs of pharmaceutical enterprises—making it easier for both large and small players to scale operations, export globally, and maintain compliance.

Here’s how the government supports the pharmaceutical sector at every level:

1. Gujarat Industrial Policy 2020 – Pharma-Focused Incentives

• The policy provides capital subsidies of up to 25% on eligible fixed assets for new and expanding pharma units.
   
• Offers interest subsidies for term loans taken by MSMEs in pharma.
   
• Full or partial reimbursement of stamp duty and electricity duty exemptions for up to 5–7 years.
   

2. Plug-and-Play Infrastructure for Pharma Parks

• The Gujarat government has developed sector-specific industrial estates, especially for pharmaceuticals, through GIDC in locations like Sanand, Dahej, and Vadodara.
   
• These zones include:
   
  • Ready-to-use factory shells
     
  • Common utilities (CETPs, power stations)
     
  • Regulatory assistance offices
     

3. PLI Scheme (Production Linked Incentive) for Pharma

• Gujarat was one of the earliest states to respond to the PLI scheme launched by the Government of India, which incentivizes:
   
  • API and key starting material production
     
  • Complex generics
     
  • Biologics and biosimilars
     
• Several pharma companies in Gujarat have already secured PLI benefits for greenfield and brownfield expansions.
   

4. Export Facilitation and Regulatory Support

• Gujarat offers:
   
  • Single-window clearance systems for export-oriented pharma firms
     
  • Access to CDSCO’s zonal and sub-zonal offices in Ahmedabad and Vadodara
     
  • State assistance in obtaining international certifications, including:
     
    • WHO-GMP
       
    • USFDA site audits
       
    • EU-GMP documentation
       

5. Support for Innovation and Research

• The state has funded the establishment of pharma and biotech incubators, such as those under the Gujarat Biotechnology Research Centre (GBRC).
   
• Offers innovation grants and mentorship to startups working on:
   
  • Drug delivery innovation
     
  • AI in pharma R&D
     
  • Clinical trial digitization
     

With this robust framework, pharma companies in Gujarat benefit from one of the most supportive ecosystems for capital investment, regulatory growth, and global market expansion.

8. Opportunities in Contract Manufacturing & APIs

As the global pharmaceutical industry becomes more cost-conscious and outsourcing-driven, Gujarat has emerged as a go-to destination for contract manufacturing and API production. This presents a massive opportunity for companies and investors looking to scale with speed, efficiency, and regulatory reliability.

1. Gujarat – India’s CRAMS Capital

• CRAMS stands for Contract Research and Manufacturing Services, a model where companies outsource:
   
  • Pre-clinical research
     
  • Pilot batches and formulation development
     
  • Commercial-scale manufacturing
     
• Gujarat is home to leading CRAMS players such as:
   
  • Dishman Carbogen Amcis
     
  • ZCL Chemicals
     
  • Synchron Research
     
• These companies support multinational brands and generic giants from the US, EU, and Japan.
   

2. End-to-End Third-Party Manufacturing

• Thousands of MSMEs and mid-size pharma companies in Gujarat offer:
   
  • Third-party formulation services
     
  • Packaging and labeling
     
  • Logistics and warehousing
     
• Common dosage forms outsourced:
   
  • Tablets, capsules, ointments, syrups
     
  • Dry powder injectables
     
  • Ayurvedic and nutraceutical lines
     

3. API and Intermediate Production Strength

• Gujarat produces a wide range of essential APIs, including:
   
  • Metformin, Diclofenac, Paracetamol
     
  • Oncology APIs and hormonal intermediates
     
• The Ankleshwar–Panoli–Vapi belt leads in volume, while Dahej SEZ is driving high-value, export-oriented API manufacturing.
   

4. Export-Centric API Growth

• Gujarat-based firms are focusing on:
   
  • Filing DMFs (Drug Master Files) with USFDA and EDQM
     
  • Setting up dedicated CEP-certified API plants for EU supply
     
  • Green chemistry approaches to reduce environmental burden
     

5. Scope for Strategic Partnerships

• Gujarat offers joint venture opportunities for:
   
  • Foreign companies looking to enter the Indian pharma supply chain
     
  • Indian pharma startups needing compliant back-end manufacturing
     
  • Healthcare brands expanding into herbal and nutraceutical categories
     

In short, Gujarat’s infrastructure, talent, regulatory preparedness, and industrial depth make it the undisputed contract manufacturing and API leader in India.

9. Employment and Career Opportunities

The robust presence of pharma companies in Gujarat has turned the state into a magnet for skilled professionals across multiple verticals in the pharmaceutical domain. From R&D to production, from quality control to logistics, Gujarat offers one of the most comprehensive and rewarding employment landscapes in Indian pharma.

1. Technical & Manufacturing Roles

• Production Chemists and Plant Supervisors
  
  Over 5,000 pharmaceutical units require skilled operators and engineers to manage manufacturing lines for formulations, APIs, and injectables.
   
• Quality Control (QC) & Quality Assurance (QA) Specialists
  
  With over 130 USFDA-approved plants, the demand for QC/QA professionals with expertise in documentation, audit readiness, and lab protocols is extremely high.
   
• Validation Engineers and Process Analysts
  
  Especially in large-scale formulation units and sterile injectable plants across Vadodara, Halol, and Ahmedabad.
   

2. Research and Development (R&D) Professionals

• Gujarat houses several state-of-the-art R&D centers that need:
   
  • Formulation scientists
     
  • Analytical chemists
     
  • Regulatory dossier experts
     
  • Clinical research associates
     
• Institutions like NIPER Gandhinagar, LM College of Pharmacy, and MS University Baroda regularly feed talent into the R&D arms of Zydus, Intas, Alembic, and Torrent.
   

3. Regulatory Affairs and International Compliance

• Professionals with knowledge of:
   
  • USFDA, MHRA, WHO-GMP audit protocols
     
  • ANDA/DMF/CEP filings
     
  • Labeling and pharmacovigilance regulations
     
• These roles are centered in Ahmedabad and Vadodara, where most regulatory departments are headquartered.
   

4. Sales, Marketing & Business Development

• Field sales teams across Gujarat promote branded generics and specialty drugs in Tier-2 and Tier-3 cities.
   
• Export sales roles are growing as pharma companies in Gujarat expand into regulated and semi-regulated markets.
   
• Franchise development, PCD onboarding, and international trade desk roles are also seeing a rise.
   

5. Digital & Automation Careers in Pharma

With increased automation in manufacturing and demand for compliance tracking, emerging job roles include:

• MES (Manufacturing Execution System) Analysts
   
• Pharma ERP (SAP/LIMS) Consultants
   
• Data Analysts for supply chain and QA metrics
   
• AI-based product development researchers
   

Whether you’re a science graduate, engineering professional, regulatory specialist, or pharma sales expert, Gujarat offers rich, future-facing career opportunities in every aspect of the pharmaceutical industry.

10. Future Trends and Outlook for Gujarat’s Pharma Sector

As India races toward becoming a $130 billion pharma economy by 2030, Gujarat is positioned to lead this charge. With policy alignment, infrastructure depth, and global regulatory credibility, the future of Gujarat’s pharmaceutical industry looks stronger than ever.

1. Expansion into Biologics and Biosimilars

• Companies like Zydus, Intas, and Torrent are ramping up R&D and manufacturing for:
   
  • Biosimilar monoclonal antibodies
     
  • Recombinant therapeutic proteins
     
  • Vaccine APIs and formulations
     
• Dedicated biotech corridors are being planned in Sanand and Ahmedabad.
   

2. Transition to Green Chemistry

• Environmental regulations and global compliance standards are pushing firms to adopt:
   
  • Solvent recovery systems
     
  • Zero liquid discharge (ZLD) protocols
     
  • Eco-friendly synthesis pathways
     
• Gujarat is setting the benchmark for sustainable pharma manufacturing in India.
   

3. Complex Generics and High-Value Molecules

• Gujarat’s R&D investment is shifting from basic formulations to:
   
  • Modified-release formulations
     
  • Transdermal delivery systems
     
  • Fixed-dose combinations (FDCs)
     
  • Oral oncology and rare disease treatments
     

4. Global Pharma Alliances and Joint Ventures

• With strong IP frameworks and global trust, pharma companies in Gujarat are entering:
   
  • Co-marketing agreements with EU/US brands
     
  • CDMO partnerships for Phase II–III drug trials
     
  • Joint manufacturing of biosimilars and injectable therapies
     

5. Government-Led Infrastructure & Innovation Push

• Upcoming API bulk drug parks under the Central Government’s support schemes
   
• Digital Pharma Parks integrated with AI, MES, and smart warehousing
   
• Startup-friendly innovation hubs linked to pharma accelerators and VCs in Ahmedabad and Vadodara
   

The future is clear: Gujarat will continue to drive India’s pharmaceutical transformation—not just as a manufacturing engine, but as a globally recognized innovation and export hub.

11. Conclusion

Gujarat stands at the forefront of India’s pharmaceutical revolution. With a perfect blend of industrial infrastructure, global regulatory credibility, and proactive government support, the state continues to shape the future of healthcare manufacturing and exports.

Throughout this guide, we explored:

• How pharma companies in Gujarat have evolved into global leaders in formulations, APIs, biologics, and CRAMS
   
• The classification of businesses across bulk drugs, biosimilars, and herbal products
   
• The top 15 pharmaceutical companies driving innovation and exports from cities like Ahmedabad, Vadodara, and Ankleshwar
   
• Industrial clusters that power India’s highest USFDA- and WHO-GMP-approved manufacturing base
   
• Gujarat’s significant contribution to India’s pharmaceutical exports—both in volume and regulatory compliance
   
• Employment opportunities for professionals in R&D, QA/QC, sales, and digital pharma
   
• How emerging trends like green chemistry, biologics, and AI-led manufacturing are redefining Gujarat’s pharma future
   

Whether you’re a business owner, distributor, policymaker, investor, or job seeker, Gujarat offers a complete ecosystem—backed by vision, capability, and scalability.

For anyone looking to work with, invest in, or understand India’s pharmaceutical sector, pharma companies in Gujarat remain an unmatched gateway to domestic and global opportunity.

FAQs about Pharma Companies in Gujarat

 

Q1. Why is Gujarat considered a pharmaceutical hub in India?

Gujarat accounts for nearly 30–40% of India’s pharmaceutical production and exports. It leads in both formulations and API manufacturing, has over 130 USFDA-approved plants, and benefits from strong government policies, world-class infrastructure, and access to international ports.

Q2. Which are the top pharma companies in Gujarat?

Some of the top pharma companies in Gujarat include Zydus Lifesciences, Torrent Pharmaceuticals, Intas Pharma, Sun Pharma (plants in Halol), Alembic Pharmaceuticals, and Cadila Pharmaceuticals. These companies are known for their global exports and regulatory compliance.

Q3. Where are the major pharma industrial zones located in Gujarat?

Key pharma clusters in Gujarat include Ahmedabad, Vadodara, Ankleshwar, Vapi, Dahej SEZ, and Sanand. These zones are supported by GIDC and have facilities for both API and formulation manufacturing.

Q4. What types of products are manufactured by pharma companies in Gujarat?

Pharma companies in Gujarat manufacture:

• Active Pharmaceutical Ingredients (APIs)
   
• Generic formulations (tablets, capsules, injectables)
   
• Biosimilars and vaccines
   
• Veterinary drugs
   
• Herbal and nutraceutical products
   

Q5. Is Gujarat a good place to invest in contract manufacturing or third-party pharma production?

Yes. Gujarat is India’s leading destination for contract manufacturing (CRAMS) and third-party pharma production. It offers regulatory infrastructure, export-ready logistics, and experienced talent, making it ideal for startups and global pharma brands alike.

Q6. What government schemes support pharma companies in Gujarat?

Pharma companies in Gujarat benefit from:

• Gujarat Industrial Policy 2020
   
• PLI (Production Linked Incentive) Scheme for pharma and APIs
   
• GIDC-developed pharma parks
   
• Export assistance and single-window regulatory support